Evidence map›Paper›PMID 20497331›Full record

ArticleMolecular microbiology2010

Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration.

Annalisa Lembo, Michael A Gurney, Kellie Burnside, Anirban Banerjee, Melissa de los Reyes, James E Connelly, Wan-Jung Lin, Kelsea A Jewell, Anthony Vo, Christian W Renken and 2 more

Abstract read
In one paragraph

Article in Molecular microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. CRISPR interference in aJournal of bacteriology · 2026
    Article
  3. Review
  4. Mechanisms and Manifestations of Group B Streptococcus Meningitis in Newborns.Journal of the Pediatric Infectious Diseases Society · 2025
    Review
  5. Analysis of serotype distribution and characteristics of nonhemolytic and nonpigmented strains among group B Streptococcus isolates in a southern Taiwan local hospital.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Group BScience advances · 2022
    Article
  12. Article
  13. Group B Streptococcal Neonatal Meningitis.Clinical microbiology reviews · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Annalisa LemboDepartment of Pediatric Infectious Diseases, University of Washington School of Medicine, Seattle, WA 98195, USA.
Michael A Gurney
Kellie Burnside
Anirban Banerjee
Melissa de los Reyes
James E Connelly
Wan-Jung Lin
Kelsea A Jewell
Anthony Vo
Christian W Renken
Kelly S Doran
Lakshmi Rajagopal
University of Washington · USSeattle Children's Hospital · USIn-Q-Tel · USUniversity of Cincinnati Medical Center · US

Funding

Blood-brain barrier in bacterial meningitisR01NS051247 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORAN, KELLY S · 2006 to 2015
$3.2M
Eukaryotic-type signaling mediates two-component regulation of GBS virulenceR01AI070749 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2007 to 2011
$2.0M
NIAID NIH HHS R01 AI070749NINDS NIH HHS R01 NS051247
6 · The paper itself

Abstract

Group B Streptococcus (GBS) is an important cause of invasive infections in humans. The pathogen encodes a number of virulence factors including the pluripotent beta-haemolysin/cytolysin (beta-H/C). As GBS has the disposition of both a commensal organism and an invasive pathogen, it is important for the organism to appropriately regulate beta-H/C and other virulence factors in response to the environment. GBS can repress transcription of beta-H/C using the two-component system, CovR/CovS. Recently, we described that the serine/threonine kinase Stk1 can phosphorylate CovR at threonine 65 to relieve repression of beta-H/C. In this study, we show that infection with CovR-deficient GBS strains resulted in increased sepsis. Although CovR-deficient GBS showed decreased ability to invade the brain endothelium in vitro, they were more proficient in induction of permeability and pro-inflammatory signalling pathways in brain endothelium and penetration of the blood-brain barrier (BBB) in vivo. Microarray analysis revealed that CovR positively regulates its own expression and regulates the expression of 153 genes. Collectively, our results suggest that the positive feedback loop which regulates CovR transcription modulates host cell interaction and immune defence and may facilitate the transition of GBS from a commensal organism to a virulent meningeal pathogen.

Indexed as

AnimalsBacterial ProteinsBlood-Brain BarrierCell LineGene Expression Regulation, BacterialHumansMaleMiceOligonucleotide Array Sequence AnalysisProtein Processing, Post-TranslationalRepressor ProteinsRNA, BacterialSepsisStreptococcal InfectionsStreptococcus agalactiaeVirulence FactorsBacterial ProteinsRepressor ProteinsRNA, BacterialVirulence Factors

Identifiers

PMID20497331
PMCPMC2909351
OpenAlexW2119685853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.